[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 77, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 303347, "exercisedValue": 0, "unexercisedValue": 50088}, {"maxAge": 1, "name": "Dr. Daniel L. Alkon M.D.", "age": 82, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1942, "fiscalYear": 2023, "totalPay": 375000, "exercisedValue": 0, "unexercisedValue": 109125}, {"maxAge": 1, "name": "Mr. Robert  Weinstein", "age": 64, "title": "CFO, Executive VP, Treasurer & Secretary", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 568918, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.68, "open": 2.6806, "dayLow": 2.6, "dayHigh": 2.7, "regularMarketPreviousClose": 2.68, "regularMarketOpen": 2.6806, "regularMarketDayLow": 2.6, "regularMarketDayHigh": 2.7, "payoutRatio": 0.0, "beta": 1.293, "trailingPE": 3.068182, "forwardPE": -0.31615925, "volume": 4697, "regularMarketVolume": 4697, "averageVolume": 17037, "averageVolume10days": 3860, "averageDailyVolume10Day": 3860, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3660147, "fiftyTwoWeekLow": 2.32, "fiftyTwoWeekHigh": 6.217, "fiftyDayAverage": 3.15592, "twoHundredDayAverage": 3.505485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -18094452, "profitMargins": 0.0, "floatShares": 1346503, "sharesOutstanding": 1355610, "sharesShort": 29806, "sharesShortPriorMonth": 26047, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.022, "heldPercentInsiders": 0.01949, "heldPercentInstitutions": 0.01082, "shortRatio": 3.49, "shortPercentOfFloat": 0.0221, "impliedSharesOutstanding": 1355610, "bookValue": 9.444, "priceToBook": 0.2858958, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -9132406, "trailingEps": 0.88, "forwardEps": -8.54, "lastSplitFactor": "1:25", "lastSplitDate": 1712275200, "enterpriseToEbitda": 2.677, "52WeekChange": -0.40638298, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 2.7, "recommendationKey": "none", "totalCash": 22069080, "totalCashPerShare": 16.28, "ebitda": -6758923, "totalDebt": 0, "quickRatio": 64.739, "currentRatio": 65.359, "returnOnAssets": -0.15322, "returnOnEquity": -0.39562, "freeCashflow": -5142445, "operatingCashflow": -4782123, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNPX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Synaptogenix, Inc.", "longName": "Synaptogenix, Inc.", "exchange": "NCM", "messageBoardId": "finmb_268943522", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607437800000, "corporateActions": [], "regularMarketTime": 1740776400, "regularMarketChange": 0.01999998, "regularMarketDayRange": "2.6 - 2.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 17037, "fiftyTwoWeekLowChange": 0.3800001, "fiftyTwoWeekLowChangePercent": 0.16379316, "fiftyTwoWeekRange": "2.32 - 6.217", "fiftyTwoWeekHighChange": -3.517, "fiftyTwoWeekHighChangePercent": -0.5657069, "fiftyTwoWeekChangePercent": -40.638298, "epsTrailingTwelveMonths": 0.88, "epsForward": -8.54, "fiftyDayAverageChange": -0.45591998, "fiftyDayAverageChangePercent": -0.144465, "twoHundredDayAverageChange": -0.805485, "twoHundredDayAverageChangePercent": -0.22977847, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-07", "prevName": "Synaptogenix", "nameChangeDate": "2025-02-28", "cryptoTradeable": false, "regularMarketChangePercent": 0.7462679, "regularMarketPrice": 2.7, "displayName": "Synaptogenix", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]